These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9448589

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?
    Capper ER, Maskill JK, Gordon C, Blakemore AI.
    Clin Exp Immunol; 2004 Nov; 138(2):348-56. PubMed ID: 15498048
    [Abstract] [Full Text] [Related]

  • 3. IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.
    Italiani P, Manca ML, Angelotti F, Melillo D, Pratesi F, Puxeddu I, Boraschi D, Migliorini P.
    Arthritis Res Ther; 2018 Feb 08; 20(1):27. PubMed ID: 29422069
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus.
    Chang DM.
    Immunol Invest; 1997 Feb 08; 26(5-7):649-59. PubMed ID: 9399106
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity.
    Suzuki H, Takemura H, Kashiwagi H.
    Arthritis Rheum; 1995 Aug 08; 38(8):1055-9. PubMed ID: 7639800
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb 08; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
    Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CG.
    Clin Exp Immunol; 1992 Oct 08; 90(1):106-10. PubMed ID: 1395090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis.
    De Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Martini A.
    Clin Exp Rheumatol; 1995 Oct 08; 13(6):779-84. PubMed ID: 8835254
    [Abstract] [Full Text] [Related]

  • 15. IL-1RA in refractory systemic lupus erythematosus.
    Moosig F, Zeuner R, Renk C, Schröder JO.
    Lupus; 2004 Oct 08; 13(8):605-6. PubMed ID: 15462491
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.